TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.

D'Souza J, Leung CJ, Ballapuram AC, Lin AS, Batingana AR, Lamble AJ, Ries RE, Morales CE, Cottonham C, Gona P, Fan L, Ma X, Shannon K, Meshinchi S, Braun BS, Huang BJ